Viatris Inc financial data

Symbol
VTRS on Nasdaq
Industry
Pharmaceutical Preparations
Location
1000 Mylan Boulevard, Canonsburg, PA
State of incorporation
DE
Fiscal year end
December 31
Former names
Upjohn Inc (to 11/10/2020)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 159 % +1.91%
Quick Ratio 49.8 % -9.94%
Operating Margin -1.76 % -127%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.19B shares -0.51%
Entity Public Float 11.9B USD -5.73%
Common Stock, Value, Issued 12.3M USD +0.82%
Weighted Average Number of Shares Outstanding, Basic 1.19B shares -0.5%
Weighted Average Number of Shares Outstanding, Diluted 1.2B shares -0.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 15B USD -2.7%
Revenue from Contract with Customer, Excluding Assessed Tax 15B USD -2.76%
Research and Development Expense 198M USD -6.06%
Operating Income (Loss) -265M USD -126%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -952M USD -138%
Income Tax Expense (Benefit) -68.4M USD -110%
Earnings Per Share, Basic -0.73 USD/shares -148%
Earnings Per Share, Diluted -0.73 USD/shares -148%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.88B USD +43.5%
Accounts Receivable, after Allowance for Credit Loss, Current 3.72B USD -0.56%
Inventory, Net 4.08B USD +11.2%
Other Assets, Current 335M USD -72%
Assets, Current 11.3B USD +3.44%
Deferred Income Tax Assets, Net 763M USD -18%
Property, Plant and Equipment, Net 2.68B USD -8.53%
Operating Lease, Right-of-Use Asset 268M USD +8.03%
Intangible Assets, Net (Excluding Goodwill) 18B USD -15.5%
Goodwill 9.56B USD -6.97%
Other Assets, Noncurrent 2.47B USD +2.96%
Assets 44.8B USD -8.18%
Employee-related Liabilities, Current 668M USD -13.4%
Liabilities, Current 7.51B USD +9.93%
Deferred Income Tax Liabilities, Net 1.28B USD -45%
Operating Lease, Liability, Noncurrent 188M USD +17.2%
Other Liabilities, Noncurrent 1.87B USD +13.5%
Liabilities 25B USD -10.5%
Accumulated Other Comprehensive Income (Loss), Net of Tax -2.69B USD +16.3%
Retained Earnings (Accumulated Deficit) 4.08B USD -26.5%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 19.8B USD -5.14%
Liabilities and Equity 44.8B USD -8.18%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 615M USD -36.7%
Net Cash Provided by (Used in) Financing Activities -426M USD +56.3%
Net Cash Provided by (Used in) Investing Activities -154M USD +79.4%
Common Stock, Shares Authorized 3B shares 0%
Common Stock, Par or Stated Value Per Share 0.01 EUR/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 22.3M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.88B USD +43.3%
Deferred Tax Assets, Valuation Allowance 421M USD +8.89%
Deferred Tax Assets, Gross 2.16B USD +6.47%
Operating Lease, Liability 248M USD -5.19%
Payments to Acquire Property, Plant, and Equipment 49.8M USD +4.18%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 384M USD +198%
Lessee, Operating Lease, Liability, to be Paid 271M USD -4.68%
Property, Plant and Equipment, Gross 4.88B USD -3.02%
Operating Lease, Liability, Current 84.2M USD -4.75%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62.7M USD -1.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 79.3M USD +3.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Deferred Income Tax Expense (Benefit) -51.9M USD -94.4%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 22.3M USD +1.36%
Lessee, Operating Lease, Liability, to be Paid, Year Three 41.5M USD +7.51%
Unrecognized Tax Benefits 273M USD -8.06%
Lessee, Operating Lease, Liability, to be Paid, Year Four 30.4M USD +0.66%
Additional Paid in Capital 18.9B USD +0.68%
Amortization of Intangible Assets 2.31B USD -3.08%
Depreciation, Depletion and Amortization 691M USD -5.34%
Deferred Tax Assets, Net of Valuation Allowance 1.74B USD +5.9%
Interest Expense 571M USD -1.49%